Search for: "Bone v. Weeks et al" Results 1 - 20 of 43
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Apr 2009, 5:10 pm
Bone Care International LLC et al. v. [read post]
23 Jan 2012, 7:34 pm by Kim Krawiec
Via Al Roth comes news that the government is fighting the recent Flynn v. [read post]
19 Feb 2018, 3:19 pm by Richard Hunt
FCA US LLC, et al., EDCV172183JFWSPX, 2018 WL 700939, at *3 (C.D. [read post]
1 May 2013, 7:29 am by Sheldon Toplitt
(Photo credit: Wikipedia)The alleged altering and commercial exploitation of a nine-year-old photo of a then-teen with Down Syndrome that went viral on the Internet prompted the 26-year-old man and his parents last week to file an $18 million suit in the United States District Court for the Middle District of Tennessee, according to reports by the Associated Press and the NashvilleCityPaper.com Web site.Holland et al. v. [read post]
15 Sep 2015, 8:20 am by Jeff Lazarus
Based on last week's rulings, I have three cases to detail:1) In United States v. [read post]
25 Mar 2007, 11:54 pm
§ 112 rejections may give rise to estoppel, no literal infringement and no infringement under the doctrine of equivalents because of Festo, defendant's redesigned screws do not meet the limitations of either claim at issueEspeed, Inc., et al. v. [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
1 May 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Tarceva (Erlotinib) – India: Delhi High Court Appellate Bench holds in favour of Cipla against Roche in Tarceva patent litigation; Roche fined for ‘material suppression’ (Spicy IP) (PatLit) (Patent Circle) (Spicy IP) (Patent Circle) (Patent Circle) (GenericsWeb) Lovenox (Enoxaparin) –… [read post]
11 Apr 2014, 11:29 am
Id. at *12 holding.Analysis on selecting "150 mg" per month DoseRavnA 1996 article by Ravn et al. [read post]